Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

‘The start of a paradigm shift’: FDA clears first over-the-counter cuffless blood pressure monitor
The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.
Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed
Researchers explored more than 52 years of data, highlighting several key trends in the Journal of the American Heart Association.
FDA finalizes new heart warnings for COVID-19 vaccines
The new warnings, first proposed to Pfizer and Moderna in April, are now officially required by the FDA. They provide additional information about the potential risks of myocarditis and/or pericarditis associated with these vaccines.
Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease
Semaglutide, tirzepatide and other GLP-1 drugs appear to provide significant value for patients with moderate PAD.
American College of Cardiology now supports early use of medication to treat obesity
The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles in any treatment decisions.

A team of researchers at Gladstone, including Bárbara González Terán shown here seated, developed a novel algorithm method for identifying genetic variants that are likely to play important roles in congenital heart disease. This opens up opportunities to accelerate research into this serious condition. Photo by Michael Short/Gladstone Institutes

Algorithm helps sort genetic data to improve our understanding of congenital heart disease

Researchers at Gladstone Institutes developed a new algorithm method for identifying genetic variant combinations that are likely to play important roles in congenital heart disease.

USPSTF shares updated recommendations on statin use to prevent CVD

The public comment period for these recommendations ends on March 21.

4 new medications and technologies that could transform cardiology in 2022

The FDA has already approved one of the medications, with a decision on another expected by the end of April.

AstraZeneca COVID-19 vaccine slightly increases risk of blood clots

Researchers emphasized that the benefits of the vaccine still far outweigh the risks.

Unreliable? 76% of world’s blood pressure monitors have not been validated

Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy.

Risk of recurrent stroke 48% higher among young marijuana users

Marijuana use can be especially harmful to young adults with a history of stroke or TIA, researchers explained.

Heart drug trimetazidine at center of Olympics controversy surrounding figure skater Kamila Valieva

Trimetazidine, typically prescribed for treating angina, is associated with increasing blood flow and improving endurance.

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

Heart Health

‘The start of a paradigm shift’: FDA clears first over-the-counter cuffless blood pressure monitor

Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed

FDA finalizes new heart warnings for COVID-19 vaccines

Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease

American College of Cardiology now supports early use of medication to treat obesity